核心产品Korlym销售表现 - Korlym是公司唯一上市药物 用于治疗库欣综合征或内源性高皮质醇血症 公司收入完全依赖该产品[1] - 2025年上半年Korlym销售额达3.516亿美元 同比增长13.2%[1][9] - 预计2025年全年Korlym销售额将达8.571亿美元 同比增长近27%[1] - 第一季度因专业药房供应商产能不足影响销售 第二季度情况改善[2] - 管理层预期下半年处方量将显著增长 全年总收入指引8.5-9亿美元[2][3] 研发管线进展 - 主要候选药物relacorilant针对库欣综合征的新药申请已于2024年12月提交FDA[4] - FDA设定处方药用户费用法案目标行动日期为2025年12月30日[4] - 获批后现有Korlym患者将全部转换至relacorilant 有望加速增长并降低对单一产品依赖[5] - 同时开发relacorilant联合疗法：与nab-紫杉醇联用治疗铂耐药卵巢癌的NDA已提交[6] - 开展II期BELLA研究 评估relacorilant联合nab-紫杉醇和罗氏Avastin治疗铂耐药卵巢癌[6][7] - 另有一项研究评估relacorilant联合默克Keytruda治疗肾上腺癌伴皮质醇过量[7] 股价表现与估值 - 年初至今股价上涨38.3% 远超行业8.3%的涨幅[8] - 按市销率计算 公司当前交易倍数11.73倍 显著高于行业2.38倍和自身五年均值7.52倍[10] - 过去60天内2025年每股收益共识预期从1.39美元下调至1.15美元 2026年从2.08美元下调至1.71美元[11]

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 2nd:Sportradar Group (SRAD) :This company which is a provider of sports betting and sports entertainment products and services, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.9% over the last 60 days.Sportradar Group's shares gained 28.9% over the last three month compared with the S&P 500’s gain of 8.8%. The company poss ...

The market expects Dave & Buster's (PLAY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss ...

就业数据发布日程 - 本周为就业数据密集发布周 所有主要月度和周度就业报告将在周五上午前集中发布[1] - 因周一假期 JOLTS报告推迟至周三发布（反映7月就业数据） ADP私营部门 payrolls推迟至周四发布（反映8月数据）[2] - 周四照常发布每周初请失业金人数 当前稳定在23万人水平[3] - 周五将发布就业形势报告（BLS） 这是特朗普解雇BLS局长后的首份报告[4] 就业数据预期 - 8月新增就业人数预期为7.5万人 略高于前值的7.3万人[4] - ADP调查同样预期新增7.5万人[5] - 长期失业救济人数连续12周保持在194万人以上 未触及200万心理关口[3] - 尽管数据改善 但仍低于婴儿潮一代和老年X世代退休造成的岗位缺口[5] 制造业数据与市场表现 - 今日将发布8月S&P制造业PMI（预期53.3 与前值持平）和ISM制造业PMI（预期48.5% 前值48.0%）[7] - 两项数据分别位于50的荣枯线上下[7] - 早盘期货下跌 主要指数跌破5个交易日前水平[8] - 30年期国债收益率升至4.99% 为7月突破5%后最高水平 10年期和2年期分别达4.30%和3.67%[8] 政策环境影响因素 - 美联储可能在未来几周降息 即便就业数据超预期达到11万人也不会改变计划[6] - 当前关税政策被高等法院裁定违法 但退还关税收益尚未成为市场关注焦点[8]

Shares of Kroger (KR) have been struggling lately and have lost 5.2% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earning ...

Bright Minds Biosciences Inc. (DRUG) closed the last trading session at $38.89, gaining 9.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $83.25 indicates an 114.1% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $7.68. While the lowest estimate of $75.00 indicates a 92.9% increase from the current price level, the most opt ...

Edgewise Therapeutics, Inc. (EWTX) closed the last trading session at $14.35, gaining 5.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $39.17 indicates a 173% upside potential.The average comprises 12 short-term price targets ranging from a low of $14.00 to a high of $51.00, with a standard deviation of $12.96. While the lowest estimate indicates a decline of 2.4% from the curr ...

SiriusPoint (SPNT) closed the last trading session at $18.72, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $25 indicates a 33.6% upside potential.The average comprises three short-term price targets ranging from a low of $20.00 to a high of $30.00, with a standard deviation of $5. While the lowest estimate indicates an increase of 6.8% from the current price level, ...

技术指标分析 - 50日简单移动平均线突破200日移动平均线形成黄金交叉形态 预示看涨突破前景 [1] - 黄金交叉包含三个阶段 价格触底反弹 短期均线上穿长期均线 最终维持上涨动能 [2] - 过去四周股价累计上涨10.4% 技术指标与Zacks买入评级形成看涨组合 [3] 盈利预期表现 - 当前季度盈利预期未出现下调 过去60天内获得1次上调 [3] - Zacks共识预期持续提升 盈利展望积极强化看涨逻辑 [3] 综合投资前景 - 技术面黄金交叉与盈利预期上调形成双重利好 支撑近期继续上涨潜力 [5]

Shares of Integer (ITGR) have gained 1% over the past four weeks to close the last trading session at $107.87, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $142.11 indicates a potential upside of 31.7%.The mean estimate comprises nine short-term price targets with a standard deviation of $7.59. While the lowest estimate of $132.00 indicates a 22.4% increase from the current p ...